Corcept Therapeutics Incorporated
CORT NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 29, 2026
ET
EPS Est.
0.02
EPS Actual
0.36
Revenue Est.
$221.1M
Revenue Actual
$256.1M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
0.81
Revenue Est.
$323.9M
Company Overview
Corcept Therapeutics Incorporated (ticker CORT) is listed on NASDAQ with a market cap of about $13.21B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), After-market, with consensus EPS of 0.81. In the last 15 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently15Term · Feb 28, 2023 → Jul 29, 2026
Feb 28, 2023Range: -0.30 ~ 0.41Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 0.02 | Above forecast↑0.36 | $221.1M | $256.1M |
| Apr 30, 2026 | -- | -0.11 | Below forecast↓-0.30 | $185.3M | $164.9M |
| Feb 24, 2026 | -- | 0.33 | Below forecast↓0.20 | $254.9M | $202.1M |
| Nov 4, 2025 | -- | 0.18 | 0.16 | $255.3M | $207.6M |
| Jul 31, 2025 | -- | 0.23 | Above forecast↑0.29 | $244.6M | $194.4M |
| May 5, 2025 | -- | 0.17 | 0.17 | $216.7M | $157.2M |
| Feb 26, 2025 | -- | 0.37 | Below forecast↓0.26 | $200.1M | $181.9M |
| Oct 30, 2024 | -- | 0.28 | Above forecast↑0.41 | $198M | $182.5M |
| Jul 29, 2024 | -- | 0.23 | Above forecast↑0.32 | $162.1M | $163.8M |
| May 1, 2024 | -- | 0.22 | 0.25 | $141.2M | $146.8M |
| Feb 15, 2024 | -- | 0.26 | 0.28 | $129.3M | $135.4M |
| Nov 1, 2023 | -- | 0.22 | Above forecast↑0.28 | $127.8M | $123.6M |
| Aug 2, 2023 | -- | 0.15 | Above forecast↑0.25 | $109.7M | $117.7M |
| May 3, 2023 | -- | 0.19 | Below forecast↓0.14 | $104.9M | $105.7M |
| Feb 28, 2023 | -- | 0.23 | Below forecast↓0.14 | $105.1M | $103.1M |
Original Filings (SEC)
10-Q2026-07-29 ↗
8-K2026-07-29 ↗
8-K2026-06-17 ↗
8-K2026-06-03 ↗
8-K2026-05-28 ↗
10-Q2026-04-30 ↗
8-K2026-04-30 ↗
8-K2026-03-25 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
